Product development starts with the screening of suitable formulations and processes to best meet the defined target product profile. These formulations/processes are analysed to identify the critical parameters potentially impacting the quality of the defined target profile. Both formulations and processes are challenged and optimized to ensure that the Drug Product can be manufactured by a robust and efficient process.

Venus Pharma GmbH is developing CTD Dossiers for parties situated in Europe and Rest of the World with assistance of our GLP accredited Research unit, Venus Medicine Research Center.

During scale-up critical parameters are established and verified with appropriate control strategies to ensure that quality attributes are consistently met for validation during routine manufacturing. Besides our dedication to quality we also focus on optimization of process ranges and robustness in order to improve manufacturing efficiency and reliability within a continuous improvement process.

Venus Pharma GmbH is actively involved in developing products as per the requirements of the respective partners and as per the stringent regulations of the respective countries. If you are looking for affordable costs, quality service & greater customer loyalty, then we are worth to be tested once to become your long term partner. We welcome every such new opportunity with full enthusiasm.

We believe, “it is not how good you think the service is, it is what your customer thinks that counts.”